May 15, 2020 at 02:13PM Alternative Procedures for Blood and Blood Components During the COVID-19 Public Health Emergency

FDA is issuing this guidance to provide a notice of exceptions and alternatives to certain requirements in Title 21 of the Code of Federal Regulations (CFR) regarding blood and blood components.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2X0OUjk